The Genetic Engineering Information Bulletin: an independent, widely sourced digest of information relevant to the genetic engineering (GE) debate  
 
Home
  GE Info Bulletins  
   
  Return to Bulletin 41  
  Support  
 
No. 41 February 2006


Farmers, Communities Benefit Little
from 'Bio-pharming'

by Brendan Coyne
The NewStandard, Dec 12, 2005


Small farmers and small Midwestern towns looking to prime the economic pump are unlikely to do so by growing genetically engineered crops for use in drug production, despite pharmaceutical marketing claims stating otherwise, an academic study released last week said.
Commissioned by the Union of Concerned Scientists, The Economics of Pharmaceutical Crops: Potential Benefits and Risks for Farmers and Rural Communities found that small farmers engaged in what is known as "bio-pharming," raising genetically engineered crops to be used in drug production, are unlikely to have enough collective or market strength to negotiate effectively with drug-making giants like Merck. Common bio-pharm crops range from food crops like corn and soybeans to tobacco and other inedible plants.
Opponents of bio-pharming warn that genetically engineering plants to produce drugs threatens the water and food supplies. Information revealed by a Minnesota Pollution Control Agency employee earlier this year appears to support the contention that chemical runoff in soil is a threat to both the food supply and the ecosystem.
Studies directly linking pharmaceutical contamination to bio-pharming are inconclusive, but there have been a few noted accidents, in which crops engineered to produce drugs spontaneously grew in fields of food crops. Contaminated yields then had to be destroyed.
In 2002, for instance, the US Department of Agriculture (USDA) found modified corn growing in an Iowa soybean field at a site used for pharma crop testing the previous year by the biotechnology company ProdiGene. Since the corn had already pollinated, the USDA ordered that all cornfor 155 acresaround be uprooted and incinerated.
The Union of Concerned Scientists concluded that because of the potential ecological damage and the lack of a clear economic benefit, farmers and farming communities should "carefully examine the pharmaceutical industry’s rosily optimistic, but unsubstantiated, portrayal of this new technology’s economic rewards."

Web Link: http://newstandardnews.net/content/?action=show_item&itemid=2668

Note that direct links to the source are provided wherever possible. Otherwise, a link to a web-posted copy on a 3rd party site is given.
Sometimes these links will expire, so the above archived copy will be the only reference.

** NOTICE: In accordance with Title 17 U.S.C. Section 107, this material is distributed for research and educational purposes only. **

 

   
 
 

From The GE Information Service
The items in this bulletin are from articles which remain the copyright of the original owners. The material is published here for educational and public interest use only.


Hard copies of the Bulletin are available.
Single issues can be purchased for $5. You can also take out an annual subscription, covering a minimum of 10 issues, for $35.


The GE Information Bulletin is a project of the GE Information Service. It presents a regular digest of significant information from an international range of sources.
We rely on donations, grants and sponsorship. Please support our work to promote informed debate regarding the responsible use of genetic engineering.
Supporters have no editorial influence.

 


The GE Information Service
PO Box 78121, Grey Lynn
Auckland, New Zealand

Editor:
Stuart Sontier
Email:
editor@GEinfo.org.nz